SLC2A1 and Alzheimer disease: A decreased expression and activity of GLUT-1 were described at the BBB of AD patients (Horwood and Davies, 1994; Erickson and Banks, 2013) and in aged transgenic mice used as animal models of AD (Hooijmans et al., 2007; Winkler et al., 2015).